crambescidin 816 has been researched along with Colorectal Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Botana, LM; Cabezas-Sainz, P; Guerra-Varela, J; López, R; Roel, M; Rubiolo, JA; Sánchez, L; Silva, SB; Thomas, OP | 1 |
1 other study(ies) available for crambescidin 816 and Colorectal Neoplasms
Article | Year |
---|---|
Marine guanidine alkaloids crambescidins inhibit tumor growth and activate intrinsic apoptotic signaling inducing tumor regression in a colorectal carcinoma zebrafish xenograft model.
Topics: Alkaloids; Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Cell Adhesion; Cell Cycle Proteins; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Cytoskeleton; Dose-Response Relationship, Drug; G1 Phase Cell Cycle Checkpoints; Guanidine; Hep G2 Cells; HT29 Cells; Humans; Inhibitory Concentration 50; MCF-7 Cells; Membrane Potential, Mitochondrial; Signal Transduction; Spiro Compounds; Time Factors; Tumor Burden; Xenograft Model Antitumor Assays; Zebrafish | 2016 |